The US Medical Plastics market is projected to grow at a modest CAGR of 6.0% during the forecast period (2021-2027). The major aspect that drives the growth of the market includes the higher demand for surgical instruments in the country. According to the Health Resources & Service Administration, as of July 2019, there were more than 113,000 candidates for an organ transplant on the US national waiting list. About 95.0% of the US adults support organ donations, however, only 58.0% are signed up as donors. Hence, such a high demand for organ transplants in the country is likely to demand for significant surgical and other medical equipment which is likely to contribute to the growth of the market over the forecast period. Furthermore, the increased prevalence of diseases among the peoples due to sedentary lifestyles and improved healthcare infrastructure of the region is also projected to propel the growth of the market during the forecast period.
The US medical plastic market is segmented on the basis of plastic type and applications. Based on the plastic type, the market is segmented as traditional plastics and engineered plastics. The traditional plastics include Polyvinylchloride (PVC), Polyethylene (PE), Polystyrene (PS), Polypropylene (PP), and Silicone. Whereas, the engineered plastics segment includes Nylon, Polycarbonate (PC), Polyoxymethylene (POM), Acrylonitrile butadiene styrene (ABS), Polymethylmethacrylate (PMMA), Polyphenylene Oxide (PPO), and others. Based on the applications, the market is segmented as disposables, diagnostic instruments, catheters and syringes, implants, dental tools, surgical instruments, medical bags, drug delivery devices, and others.
Further, BASF SE, Celanese Corp., Dow DuPont Inc., Eastman Chemical Co., Evonik Industries AG, Exxon Mobil Corp., Royal DSM NV, SABIC, Saint-Gobain S.A, Solvay SA, and Trinseo S.A among others are some of the prominent players functioning in the US medical plastics market. New product launches & developments, partnerships, agreements, and acquisitions are some of the growth strategies adopted by the players in order to sustain in the highly competitive market.
Research Methodology
The market study of the US medical plastics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary sources include:
The report is intended for medical plastics manufacturing companies, chemical companies, medical devices and component manufacturers, research institutes, other related companies, and government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
Market Segmentation:
The Report covers:
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. US Medical Plastics Market by Plastic Type
5.1.1. Traditional Plastics
5.1.1.1. Polyvinylchloride(PVC)
5.1.1.2. Polyethylene (PE)
5.1.1.3. Polystyrene (PS)
5.1.1.4. Polypropylene (PP)
5.1.1.5. Silicone
5.1.2. Engineered Plastics
5.1.2.1. Nylon
5.1.2.2. Polycarbonate (PC)
5.1.2.3. Polyoxymethylene (POM)
5.1.2.4. Acrylonitrile butadiene styrene (ABS)
5.1.2.5. Polymethylmethacrylate (PMMA)
5.1.2.6. Polyphenylene Oxide (PPO)
5.1.2.7. Others (Polyetheretherketone (PEEK))
5.2. US Medical Plastics Market by Application
5.2.1. Disposables
5.2.2. Diagnostic Instruments
5.2.3. Catheters and Syringes
5.2.4. Implants
5.2.5. Dental Tools
5.2.6. Surgical Instruments
5.2.7. Medical Bags
5.2.8. Drug Delivery Devices
5.2.9. Others (Sterilization Trays, Wound Care, Anesthetic and Imaging Equipment &Other Medical Devices)
6. Company Profiles
6.1. BASF SE
6.2. Celanese Corp.
6.3. Dow DuPont Inc.
6.4. Eastman Chemical Co.
6.5. Evonik Industries AG
6.6. Exxon Mobil Corp.
6.7. Mitsubishi Chemical Corp.
6.8. Orthoplastics Ltd.
6.9. Royal DSM NV
6.10. SABIC
6.11. Saint-Gobain S.A
6.12. Solvay SA
6.13. Tekni-Plex, Inc.
6.14. Trelleborg AB
6.15. Trinseo S.A.
1. US MEDICAL PLASTICS MARKET RESEARCH AND ANALYSIS BY PLASTIC TYPE, 2020-2027 ($ MILLION)
2. US MEDICAL PLASTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
1. US MEDICAL PLASTICS MARKET SHARE BY PLASTIC TYPE, 2020 VS 2027 (%)
2. US MEDICAL PLASTICS MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)